Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study will evaluate the effect of CYP3A weak inducer rufinamide on the pharmacokinetics (PK) of Quizartinib in healthy subjects
Epistemonikos ID: 35c651d0f875c776b8385afca5cb8100371534a0
First added on: Jan 01, 2025